Askins, D.H. (2025) “Evolving role of the Interleukin-5 antagonist mepolizumab for hypereosinophilic syndrome: pathogenesis and advances in therapy - A narrative review”, Advancements in Health Research, 2(1). doi:10.4081/ahr.2025.29.